China National Accord Medicines Corporation Ltd. (SHE: 000028)

China National Accord Medicines Corporation Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6,007	6,502	6,016	5,126	5,998	8,886
Short-Term Investments	-	-	-	-	287.13	275.36
Cash & Short-Term Investments	6,007	6,502	6,016	5,126	6,285	9,161
Cash Growth	5.39%	8.08%	17.37%	-18.44%	-31.39%	13.15%
Accounts Receivable	24,013	20,235	16,202	17,701	15,842	11,953
Other Receivables	802.97	265.56	66.85	87.26	178.77	169.63
Receivables	24,816	20,539	16,306	17,855	16,067	12,168
Inventory	8,381	7,989	7,836	7,622	6,285	5,063
Other Current Assets	688.68	1,340	1,550	1,246	624.39	503.64
Total Current Assets	39,893	36,370	31,708	31,848	29,262	26,896
Property, Plant & Equipment	3,942	3,724	3,407	3,494	3,258	2,734
Long-Term Investments	3,071	2,947	2,799	2,658	2,507	2,361
Goodwill	2,747	2,747	2,750	2,776	2,747	1,010
Other Intangible Assets	593.98	615.59	647.52	669.93	734.35	374.79
Long-Term Accounts Receivable	14.1	15.91	13.68	16.59	7	-
Long-Term Deferred Tax Assets	236.04	220.48	185.25	129.74	92.12	63.11
Long-Term Deferred Charges	517.86	526.58	572.55	633.98	457.71	373.53
Other Long-Term Assets	391.31	404.42	532.4	557.38	528.64	216.26
Total Assets	51,405	47,571	42,616	42,784	39,595	34,029
Accounts Payable	19,412	17,952	15,233	16,718	15,218	12,260
Accrued Expenses	644.55	799.35	998.17	753.2	812.86	561.1
Short-Term Debt	5,080	2,903	2,133	2,490	2,200	2,318
Current Portion of Long-Term Debt	-	17	45.14	-	-	31.64
Current Portion of Leases	1,045	1,002	867.85	848.33	748.73	580.28
Current Income Taxes Payable	135.2	205.9	237.8	178.87	173.02	127.7
Current Unearned Revenue	433.59	456.3	586.96	450.59	380.95	303.19
Other Current Liabilities	922.67	1,003	926.05	939.8	724.62	782.05
Total Current Liabilities	27,673	24,338	21,028	22,379	20,258	16,964
Long-Term Debt	-	-	17.5	71.64	31.64	-
Long-Term Leases	1,665	1,452	1,327	1,375	1,303	1,208
Long-Term Unearned Revenue	72.18	74.97	80.91	87.72	90.64	89.5
Long-Term Deferred Tax Liabilities	139.62	146.05	156.48	175.95	205.92	118.28
Other Long-Term Liabilities	505.9	581.45	560.3	670.52	815.81	73.26
Total Liabilities	30,056	26,593	23,171	24,761	22,706	18,455
Common Stock	556.57	556.57	428.13	428.13	428.13	428.13
Additional Paid-In Capital	4,261	4,261	4,357	4,372	4,373	4,471
Retained Earnings	12,955	12,590	11,333	10,103	9,109	7,966
Comprensive Income & Other	7.85	7.87	7.91	21.87	38.48	45.92
Total Common Equity	17,780	17,415	16,126	14,925	13,948	12,911
Minority Interest	3,569	3,563	3,319	3,097	2,940	2,663
Shareholders' Equity	21,349	20,978	19,445	18,022	16,889	15,574
Total Liabilities & Equity	51,405	47,571	42,616	42,784	39,595	34,029
Total Debt	7,790	5,374	4,391	4,786	4,283	4,139
Net Cash (Debt)	-1,783	1,129	1,626	340.48	2,002	5,022
Net Cash Growth	-	-30.58%	377.51%	-82.99%	-60.14%	6.72%
Net Cash Per Share	-3.21	2.03	2.92	0.61	3.60	9.02
Filing Date Shares Outstanding	556.57	556.57	556.57	556.57	556.57	556.57
Total Common Shares Outstanding	556.57	556.57	556.57	556.57	556.57	556.57
Working Capital	12,220	12,032	10,681	9,469	9,005	9,932
Book Value Per Share	31.95	31.29	28.97	26.82	25.06	23.20
Tangible Book Value	14,439	14,053	12,728	11,479	10,467	11,526
Tangible Book Value Per Share	25.94	25.25	22.87	20.63	18.81	20.71
Buildings	746.89	741.11	738.01	725.86	704.64	603.85
Machinery	1,347	1,294	1,132	1,027	888.91	742.2
Construction In Progress	19.04	35.44	35.17	49.85	46.63	31.58

Source: S&P Capital IQ. Standard template. Financial Sources.